Edward T. Mathers - Jun 28, 2023 Form 4 Insider Report for Trevi Therapeutics, Inc. (TRVI)

Role: Director
Signature: /s/ Louis Citron, attorney-in-fact
Stock symbol: TRVI
Transactions as of: Jun 28, 2023
Transactions value $: $0
Form type: 4
Date filed: 6/30/2023, 04:14 PM
Previous filing: Jun 26, 2023
Next filing: Jul 19, 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TRVI	Nonstatutory Stock Option (right to buy)	Award	$0	+30K		$0.00	30K	Jun 28, 2023	Common Stock	30K	$2.27	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on June 28, 2023. This option is scheduled to fully vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the next annual meeting of stockholders of the Issuer held following the date of grant, subject to the recipient's continued service as a director, employee or consultant of the Issuer.